Bob Bollinger, MD, MPH

Role: 
Director
Raj and Kamla Gupta Professor of Infectious Diseases, Professor of Medicine, Public Health, and Nursing

Dr. Bollinger is the Raj and Kamla Gupta Professor of Infectious Diseases at the Johns Hopkins University (JHU) School of Medicine, and he holds joint appointments in International Health at the Johns Hopkins (JH) Bloomberg School of Public Health, and in Community Public Health at the JH School of Nursing. He is Founding Director of the Center for Clinical Global Health Education (CCGHE), Associate Director for Medicine of the JH Center for Global Health, and serves on the Advisory Team for the Johns Hopkins Precision Medicine Center of Excellence for COVID-19. He is board certified by the American Board of Internal Medicine in internal medicine and infectious diseases. 

Dr. Bollinger has more than 40 years of experience in international public health, clinical research, and education dealing with such global health priorities as HIV/AIDS, malaria, tuberculosis, leprosy, dengue, antibiotic resistant infections and other emerging diseases. His research interests include identifying biological and behavioral risk factors for HIV transmission; characterizing the clinical progression and treatment of HIV and related infections; development/evaluation of novel point-of-care diagnostics and implementation of research projects to optimize healthcare capacity and delivery in resource-limited settings. Working with partners in more than 20 countries, Dr. Bollinger and CCGHE faculty pioneered the development and use of distance learning and the award-winning emocha mobile health platform. He has been invited to participate in public health training programs and expert committees in more than 15 countries. He is former Director of the JHU Fogarty India Program, and he served as a member of the US Presidential Advisory Council for HIV/AIDS (PACHA), the PACHA International Sub-committee, the Institute of Medicine Forum on Public-Private Partnerships for Global Health and Safety, and the NIH Fogarty International Center Advisory Board.

Dr. Bollinger is committed to improving the health of people living in resource-limited communities through clinical research, education, and leadership training. He established health research and education programs in countries throughout Africa, South and Central America, Southeast Asia, and the Middle East. In 1991, he initiated an NIH-funded Indo-US HIV research program in Pune, India, involving the National AIDS Research Institute/ICMR and the BJ Government Medical College. He has served as Principal Investigator for many NIH-supported studies and clinical trials in Pune, including the SWEN study, which led to changes in World Health Organization (WHO) guidelines for treatment of infants born to HIV positive mothers to prevent mother-to-child transmission. Under his 26 years as leader of the Hopkins India Fogarty International Research Training Program, short-term and degree training has been provided to more than 140 visiting Indian scientists at JHU, and in-country training has been provided to more than 2,000 Indian scientists. His commitment to education has been honored with the Johns Hopkins Department of Medicine David M. Levine Excellence in Mentoring Award.

Dr. Bollinger is author of more than 200 peer-reviewed research publications and 15 book chapters, including the first and largest studies of risk factors for HIV transmission in India, the cloning and sequencing of the first HIV viruses from India, the only studies characterizing the primary immune response to HIV in India, and the demonstration of increased risk of HIV acquisition with recent HSV infection and lack of circumcision.

Dr. Bollinger received an undergraduate degree from Haverford College, a Doctor of Medicine from Dartmouth Medical School, and a Master of Public Health from JH Bloomberg School of Public Health. He completed his internal medicine training at the University of Maryland Medical Systems, followed by a post-doctoral fellowship in infectious diseases at JHU School of Medicine.

Research Program Building and Leadership

  • 1981-1982 Member, Dartmouth Medical School Admissions Committee, Hanover, NH
  • 1993: Faculty Advisor, Graduate Program in Vaccine Development Evaluation and Policy Track, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health
  • 1994-1995: Member, Molecular and Clinical Research Council, Johns Hopkins University, School of Medicine
  • 1999-2000: Member, Review Committee for the Department of International Health, Johns Hopkins Bloomberg School of Public Health
  • 2001: Chair, Hopkins Bioterrorism Clinical Management Working Group Member, Length-of-Stay Committee Johns Hopkins Department of Medicine
  • 2004: Member, Clinical Care Safety and Quality Improvement Committee, Johns Hopkins Department of Medicine
  • 2007: Member, Advisory Committee, Global Health and Foreign Policy Initiative, Johns Hopkins School of Advanced International Studies
  • 2004-2010: Member, Advisory Board, Johns Hopkins Medicine Point of Care Information Technology (POC-IT) Center
  • 2006, 2011: Member, International Health Review Committee, Johns Hopkins Bloomberg School of Public Health
  • 1992-2012: Executive Committee Member, Johns Hopkins University Fogarty International Center Program of International Training Grants in Epidemiology Related to AIDS
  • 2005-2012: Associate Director, Center for Global Health The Johns Hopkins University, Department of Medicine
  • 2008-present: Member, Consortium Working Group, Johns Hopkins, University of Washington, University of California San Francisco, University of Pennsylvania Consortium of Academic Centers Committed to Cross-Disciplinary Global Health Training and Mentorship
  • 2009-present: Member, Infectious Diseases Fellowship Recruitment and Selection Committee, Johns Hopkins University
  • 2011-present: Member, JHU Global mHealth Initiative (GMI), Johns Hopkins Bloomberg School of Public Health
  • 2012-present: Member, Johns Hopkins InHealth, Johns Hopkins Bloomberg School of Public Health
  • 2013-present: Member, Faculty Advisory Committee on International Activities (FACIA), Johns Hopkins University
  • 2013-present: Member, Advisory Board of Centro SOL (Salud/Health and Opportunity for Latinos), Johns Hopkins Bayview
  • 2013-2018: Director, miLab Project with imec and miDiagnostics 
  • 2014-present: Member, Advisory Board Center for Global Initiatives, Johns Hopkins University School of Nursing 
  • 2017-2020: Advisory Board Member, NIH Fogarty International Center 
  • 2017-present: Member, Fogarty African Bioethics Consortium - Post-Doctoral Fellowship (FABC-PDF), Training Advisory Committee, Johns Hopkins International Health
  • 2020-present: Advisory Team Member, Johns Hopkins Precision Medicine Center of Excellence for COVID-19

Visual Field Loss in HIV-Positive Patients of Non-Infectious HIV Retinopathy

Post Date: 
2019-06-02
   |   
Countries: 
   |   
Clinical Sites: 
New study will assess HIV+ patients and determine the prevalence of visual field loss due to noninfectious HIV retinopathy

Prevalence of Tuberculosis in Severely Malnourished Indian Children

Post Date: 
2018-12-18
   |   
Countries: 
   |   
Clinical Sites: 
This study is funded and conducted under the U.S. National Institutes of Health, Fogarty International Center. PIs are Robert Bollinger, MD, MPH; Dr. Muralidhar Tambe, BJGMC Severely malnourished children are vulnerable population for communicable and non-communicable disease. Diagnosis of TB among...

Characterization of TB-specific T Cell Responses in Highly-exposed, but Uninfected Health Care Workers in India

Post Date: 
2018-10-25
   |   
Countries: 
   |   
Clinical Sites: 
This study is funded and conducted under the U.S. National Institutes of Health, Fogarty International Center. PIs are Robert Bollinger, MD, MPH; Jyothi Rengarajan, MD, Emory University. Primary Research Question Do health care workers who remain TST negative, despite high-exposure to TB,...

Assessing the Impact of Psychosocial Involvement in Health Care Workers with and without Active Tuberculosis at the Byramjee Jeejeebhoy Government Medical College, Pune, India

Post Date: 
2018-09-13
   |   
Countries: 
   |   
Clinical Sites: 
This study is funded and conducted under the U.S. National Institutes of Health, Fogarty International Center. The overall goal is to understand the psychosocial involvement in health care workers with and without active tuberculosis. The specific aims of this study are: To understand the...

Gut Microbiota of HIV Infected Pregnant Women

Post Date: 
2018-06-14
   |   
Countries: 
   |   
Clinical Sites: 
Birth Outcomes in HIV Both antiretroviral-therapy (ART)-naïve and ART-experienced HIV-infected pregnant women have higher incidences of pre-term birth (PTB) compared to HIV-uninfected women. For example, the global prevalence of PTB is around 8%, while the rates in in HIV-infected populations are...

Optimal Approach for TB Screening among HIV Infected Indian Children

Post Date: 
2018-06-11
   |   
Countries: 
   |   
Clinical Sites: 
This study was terminated May 20, 2019. It was funded by the Fogarty International Center at the U.S. National Institutes of Health. Determining TB status (ie, uninfected, latent, and active TB disease) is more difficult among children, particularly HIV-infected children. Diagnosis of TB disease is...

Assessing the Impact of the Fogarty HIV-TB Training Program at the Byramjee Jeejeebhoy Government Medical College, Pune, India

Post Date: 
2018-01-19
   |   
Countries: 
   |   
Clinical Sites: 
This study was terminated in January 2021. It was funded by the Fogarty International Center at the U.S. National Institutes of Health. Johns Hopkins University was funded in 2013 to establish a new post-doctoral training program in HIV-TB epidemiology, clinical and laboratory research, for junior...

Perceptions of HCWs on Barriers and Opportunities to Airborne Infection Control Guideline Implementation

Post Date: 
2017-12-07
   |   
Countries: 
   |   
Clinical Sites: 
This study was terminated in December 2020 It was funded and conducted under the U.S. National Institutes of Health, Fogarty International Center. Led by Dr. Nishi Suryavanshi, this qualitative, cross-sectional study is assessing healthcare worker (HCW) perceptions about barriers and facilitators...

The Role of GeneXpert in Bacterial Diagnosis of Spinal Tuberculosis

Post Date: 
2017-10-25
   |   
Countries: 
   |   
Clinical Sites: 
This study was teriminated June 19, 2019. It was funded by the Fogarty International Center at the U.S. National Institutes of Health. India has the maximum burden of tuberculosis (TB) in the world. In 2014, there were an estimated 9.6 million incident cases of TB (range, 9.1 million–10.0 million)...

Zika Surveillance among Antenatal Clinic Outpatients in BJ Government Medical College and Sassoon General Hospitals, Pune, India

Post Date: 
2017-08-31
   |   
Countries: 
   |   
Clinical Sites: 
This study was terminated July 21, 2020. Zika virus is a vector-borne disease carried by the mosquito Aedes aegypti . Pregnant women infected with Zika may pass the virus to the fetus, which may cause microcephaly and other severe brain defects. It is also linked to miscarriage, stillbirth, and...

Risk Factors for Unfavourable Treatment Outcomes among Multidrug-Resistant Tuberculosis Patients in Public Sector Treatment in Pune

Post Date: 
2017-03-29
   |   
Countries: 
This study is funded and conducted under the U.S. National Institutes of Health, Fogarty International Center. This study seeks to identify risk factors associated with unfavourable treatment outcomes (death, treatment failure, default, XDR-TB) among multidrug-resistant tuberculosis (MDR-TB)...

Prevalence and Risk Factors for Oral Cancer among HIV-Infected Adults

Post Date: 
2016-12-13
   |   
Countries: 
   |   
Clinical Sites: 
The study is designed as a cross-sectional, single time point study for opportunistic oral cancer screening of HIV-infected and non- HIV adults 21 years or older in an urban hospital. All participants will undergo screening for oral cancer and oral potentially malignant disorders (OPMD) by visual...

Cost-effectiveness of Xpert MTB/RIF for Diagnosing Pulmonary Tuberculosis in HIV-positive Patients

Post Date: 
2016-12-01
   |   
Countries: 
   |   
Clinical Sites: 
This study was terminated October 8, 2019. This is a prospective cross-sectional study which will be conducted at BJGMC in Pune, India. The aim of this study is to see whether Xpert MTB/RIF is useful for early detection of pulmonary tuberculosis, and therefore cost-effective, as compared with...

The Evaluation of Clinical Profile and Mortality of Children Admitted with Tuberculosis in Pediatric Intensive-Care Unit at Sassoon General Hospitals, Pune

Post Date: 
2016-10-27
   |   
Countries: 
   |   
Clinical Sites: 
This study was terminated October 27, 2019. Tuberculosis (TB) is one of the most common causes of infection-related death globally. TB was declared global public health emergency in 1993 by World HealthOrganization (WHO). Mortality due to TB is increasing due to emergence of multidrug resistant (...

Adherence to Indian National Guidelines for Isoniazid Chemoprophylaxis among Pediatric Contacts of Pulmonary Tuberculosis Cases

Post Date: 
2016-07-06
   |   
Countries: 
   |   
Clinical Sites: 
This study was terminated June 19, 2019. The primary objective of the study was to assess the implementation of the Indian Revised National Tuberculosis Programme's (RNTCP) guidelines regarding isoniazid preventive treatment (IPT) for children under 6 years of age who had been in contact with...

A Randomized Therapeutic Interventional Comparative Study between Three Different Modalities of Paediatric Antitubercular Treatment

Post Date: 
2016-06-13
   |   
Countries: 
   |   
Clinical Sites: 
This study was terminated July 6, 2019. It was funded by the Fogarty International Center at the U.S. National Institutes of Health. This study evaluated three different TB treatment regimens in children attending Sassoon General Hospital in Pune, India. A convenience sample size of n=100 children...

Optimal Algorithmic Diagnosis of Genital TB among HIV-infected and Uninfected Infertile Women

Post Date: 
2016-05-26
   |   
Countries: 
   |   
Clinical Sites: 
This study was terminated March 2020. It was funded by the Fogarty International Center at the U.S. National Institutes of Health. There is a lack of a set protocol universally for diagnosis of genital TB, and for Indian hospitals, India's Revised National Tuberculosis Control Program (RNTCP) also...

Barriers to Early Treatment Initiation in Childhood Tuberculosis in High Incidence Setting

Post Date: 
2016-04-21
   |   
Countries: 
   |   
Clinical Sites: 
This study was terminated October 25, 2019. Funded by the Fogarty International Center and led by PI Dr. Chhaya Tukaram Valvi, the aim of this study is to evaluate the time to treatment initiation and barriers to early treatment initiation in childhood tuberculosis. TB diagnosis in children is...

Barriers to Implementation of Isoniazid Preventive Treatment (IPT) in Pediatric Contacts of Sputum Positive Adults with Tuberculosis

Post Date: 
2016-03-24
   |   
Countries: 
   |   
Clinical Sites: 
This study was terminated January 3, 2019. It was funded by the Fogarty International Center at the U.S. National Institutes of Health. Young children infected with M.tuberculosis can rapidly progress to pulmonary and extrapulmonary disease with high rates of mortality and morbidity. Studies...

miDOT (Directly Observed Therapy)

Post Date: 
2015-11-01
Designed by Dr. Maunank Shah, the miDOT mobile health application is a video-based Directly Observed Therapy interface that uses the emocha Mobile Health platform to remotely connect patients on long-term tuberculosis therapy with clinicians who are required to witness patients taking...

Pages

Utility of the interferon-gamma release assay for latent tuberculosis infection screening among indian health-care workers

Post Date: 
2021-07-13
   |   
Countries: 
Publication: 
Indian Journal of Community Medicine
Background: The utility of interferon-gamma release assays (IGRAs) for latent tuberculosis infection (LTBI) screening among health-care workers (HCWs) in low- and middle-income countries (LMICs) remains unclear. Methods: This was a prospective cohort study among HCW trainees undergoing annual LTBI...

Novel community health worker strategy for HIV service engagement in a hyperendemic community in Rakai, Uganda: A pragmatic, cluster-randomized trial

Post Date: 
2021-07-07
   |   
Countries: 
Publication: 
PLOS Medicine
Background: Effective implementation strategies are needed to increase engagement in HIV services in hyperendemic settings. We conducted a pragmatic cluster-randomized trial in a high-risk, highly mobile fishing community (HIV prevalence: approximately 38%) in Rakai, Uganda, to assess the impact of...

Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19

Post Date: 
2021-03-24
   |   
Countries: 
Publication: 
JAMA Network Open
Just Published in JAMA Network Open: In this retrospective analysis, remdesivir was associated with faster clinical improvement of COVID-19 in a cohort of predominantly non-White patients

Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian men

Post Date: 
2021-03-10
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
International Journal of Tuberculosis and Lung Disease
This study by Samyra Cox and colleagues highlights the need for integrating effective alcohol interventions into TB care.

Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19

Post Date: 
2021-03-02
Publication: 
Annals of Internal Medicine
Dr. Matt Robinson and colleagues developed a real-time tool that can predict severe disease or death among COVID patients

Higher interleukin-6 levels and changes in transforming growth factor-β are associated with lung impairment in pulmonary tuberculosis

Post Date: 
2021-01-18
   |   
Countries: 
Publication: 
ERJ Open Resource
Higher levels of IL-6 and slow-to-resolve TGF-β are associated with lung impairment in treated tuberculosis. These results have important implications for clinical trials of immunomodulatory therapies to prevent tuberculosis-associated lung disease. http://openres.ersjournals.com/lookup/doi/...

Detection of genital tuberculosis among women with infertility using best clinical practices in India: An implementation study

Post Date: 
2021-01-15
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
Indian Journal of Tuberculosis
Background Diagnosis of genital tuberculosis (TB) as a cause of infertility still remains a diagnostic dilemma for clinicians, as no standard guidelines exist. The recently proposed best practices for genital TB diagnosis have not been evaluated yet in India. Objectives To implement best practices...

Higher IL-6 Levels and Changes in TGF-β are Associated with Lung Impairment in Pulmonary Tuberculosis

Post Date: 
2021-01-08
   |   
Countries: 
Publication: 
ERJ
Pulmonary tuberculosis (PTB) is associated with granuloma formation, necrosis and cavitation in lung tissue. Lung injury in PTB can persist despite microbiological cure and is associated with chronic obstructive pulmonary disease (COPD) independent of smoking exposure[1]. Furthermore, pulmonary...

Novel community health worker strategy for HIV service engagement in a hyperendemic community in Rakai, Uganda: A pragmatic, cluster-randomized trial

Post Date: 
2021-01-06
   |   
Countries: 
Publication: 
PLOS Medicine
Effective implementation strategies are needed to increase engagement in HIV services in hyperendemic settings. We conducted a pragmatic cluster-randomized trial...

Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India

Post Date: 
2020-07-29
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
PLoS One
PLoS One: Dr. Mandar Paradkar and colleagues conducted a CTRIUMPH study that supports TB preventive therapy for all household contacts of pulmonary TB patients in India

Impact of the Fogarty Training Program on Trainee and Institutional Research Capacity Building at a Government Medical College in India

Post Date: 
2020-07-27
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
Annals of Global Health
Gauri Dumal and colleagues assess the impact of the 5-year HIV-TB research training program on building individual research capacity at BJGMC.

A mobile health-facilitated behavioral intervention for community health workers improves exclusive breastfeeding and early infant HIV diagnosis in India: A cluster randomized trial

Post Date: 
2020-07-02
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
Journal of the International AIDS Society
When community health workers used a mobile health intervention with HIV+ women to deliver care, there was a higher uptake of exclusive breastfeeding at two months and early infant HIV diagnosis at six weeks

Acceptability and Feasibility of a Behavioral and Mobile Health Intervention (COMBIND) Shown to Increase Uptake of Prevention of Mother to Child Transmission (PMTCT) Care in India

Post Date: 
2020-05-23
   |   
Countries: 
Publication: 
BMC Public Health
A cluster-randomized trial recently demonstrated that an integrated behavioral and mobile technology intervention improved uptake of key components of a Prevention of Mother to Child Transmission (PMTCT) Option B+ program, among HIV- infected pregnant/breastfeeding women in India.

Compliance of private pharmacies in Uganda with controlled prescription drugs regulations: A mixed-methods study

Post Date: 
2020-02-08
   |   
Countries: 
Publication: 
Substance Abuse Treatment, Prevention, and Policy
Background: Controlled prescription drug use disorders are a growing global health challenge in Sub-Saharan Africa. Effective supply chain regulations on dispensing and stock control are important for controlling this epidemic. Since compliance with these regulations in resource-limited countries...

Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV

Post Date: 
2019-12-20
Publication: 
Lancet HIV
Lancet HIV: Dr. Bob Bollinger and colleagues discuss the urgent need and opportunity to include activity against Hepatitis B in formulations of long-acting drugs for HIV prevention and treatment

MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patients

Post Date: 
2019-10-31
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
Infection, Genetics, and Evolution
Infection, Genetics, and Evolution : We investigated the association of TIRAP variants with severity of TB disease and IP-10 production in humans, which may be useful in predicting poor clinical outcome

Delays and barriers to early treatment initiation for childhood tuberculosis in India

Post Date: 
2019-10-01
Publication: 
International Journal of Tuberculosis and Lung Disease
BACKGROUND: India accounts for 27% of global childhood tuberculosis (TB) burden. Understanding barriers to early diagnosis and treatment in children may improve care and outcomes. METHODS: A cross-sectional study was performed among 89 children initiated on anti-TB treatment from a public hospital...

Evaluation of miLINC to shorten time to treatment for rifampicin-resistant Mycobacterium tuberculosis

Post Date: 
2019-09-01
Publication: 
The International Journal of Tuberculosis and Lung Disease
A suite of mobile health applications shows promise for linking more drug-resisitant TB patients to care and in less time.

High risk for latent tuberculosis infection among medical residents and nursing students in India

Post Date: 
2019-07-07
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
PLoS One
PLoS ONE: Self-reported TB exposure is underreported, and uptake of LTBI prevention therapy remains low

Users beware! Biological variation in complete blood counts over short time intervals

Post Date: 
2019-05-29
Publication: 
BMJ Evidence Based Medicine
New publication in BMJ Evidence Based Medicine looks at CBC count variations in blood drawn over a short time period

Pages

Pandemic Response

Post Date: 
2021-04-29
Bollinger R. Panelist. Pandemic Response. Maryland-National Capital Region Emergency Response System 2021 Virtual Symposium. Apri 28-29, 2021.

COVID-19 Lessons Learned

Post Date: 
2021-04-27
   |   
Clinical Sites: 
Bollinger R. Speaker. COVIS-19 Lessons Learned. 47th Annual Annual Conference of Research Society, BJGMC and Sassoon General Hospital. Virtual confernece, based in Pune, India. Apri 28-29, 2021.

Tuberculosis preventive therapy should be considered for all household contacts of pulmonary TB patients in India

Post Date: 
2020-02-07
   |   
Countries: 
   |   
Clinical Sites: 
Paradkar M, Chandrasekara P, Jain D, Shivakumar SVBY, Thiruvengadan K, Gupte AN, Thomas B, Kinikar A, Sekar K, Bharadwaj R, Dolla CK, Gaikwad S, Elilarasi S, Lokhande R, Reddy D, Murali L, Kulkarni V, Pradhan N, Hanna LE, Pattabiraman S, Kohli R, Nayagam R, Suryavanshi N, Shrinivasa BM, Cox SR,...

Does treatment of infertile women with probable genital tuberculosis improve fertility outcome?

Post Date: 
2019-11-01
   |   
Countries: 
   |   
Clinical Sites: 
Naik SN , Chandanwale A, Kadam D, Sambarey PW, Dhumal G, DeLuca A, Jain D, Gupta A, Bollinger R, Mave V. Does treatment of infertile women with probable genital tuberculosis improve fertility outcome? Poster presentation. 50th Union World Conference on Lung Health. Hyderabad, India. October 30-...

IL-6, TIMP-2 and TGFβ-2 Are Associated with Respiratory Impairment During and Following Successful Treatment of Pulmonary Tuberculosis

Post Date: 
2019-02-04
   |   
Countries: 
   |   
Clinical Sites: 
Gupte A , Paradkar M, Selvaraju S, Kumar P, Lokhande R, Kulkarni V, Hanna LE, Thiruvengadam K, Sekar K, Momin A, Shivakumar SVBY, Gupte N, Babu S, Salvi S, Golub J, Checkley W, Bollinger RC, Andrade B, Mave V, Chandrasekaran P, Gupta A. IL-6, TIMP-2 and TGFβ-2 are associated with respiratory...

Impact of Fogarty HIV-TB Training Program on ‘Institutional Research Capacity Building’ at the Byramjee Jeejeebhoy Government Medical College (BJGMC), Pune, India

Post Date: 
2018-10-26
   |   
Clinical Sites: 
Dhumal G, DeLuca A, Chandanwale A, Kadam D, Joshi S, Kinikar A, Suryavanshi N, Mave V, Gupta A, Bollinger R. Impact of Fogarty HIV-TB Training Program on ‘Institutional Research Capacity Building’ at the Byramjee Jeejeebhoy Government Medical College (BJGMC), Pune, India. Session: Building...

Utility of QGIT as an Adjunct to TST for Screening of Latent Tuberculosis Infection among Indian Healthcare Workers

Post Date: 
2018-10-25
Girish S, Kinikar A, Pardeshi G, Shelke S, Basavaraj A, Chandanwale A, Gupte N, Bollinger R. Utility of QGIT as an Adjunct to TST for Screening of Latent Tuberculosis Infection among Indian Healthcare Workers. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands. October 24...

High Prevalence of Dengue among Pregnant Women in India

Post Date: 
2018-08-27
   |   
Countries: 
   |   
Clinical Sites: 
Alexander M, Naik S, Robinson M , Sapkal G, Deshpande P, Kulkarni V, Nimkar S, Sambarey P, Kinikar A, Mave V, Suryavanshi N, Gupte N, Bollinger R, Gupta A, Bharadwaj R, Mathad J. High Prevalence of Dengue among Pregnant Women in India. 2018 International Conference on Emerging Infectious Diseases...

Mobile Health and Behavioral PMTCT Intervention among Community Health Workers Improves Exclusive Breastfeeding and Early Infant Diagnosis in India: A Cluster Randomized Trial

Post Date: 
2018-07-24
   |   
Countries: 
   |   
Clinical Sites: 
Suryavanshi N, Kadam A, Hegde A, Sivalenka S, Kumar VS, McKenzie-White J, Kanade S, Gupta A, Bollinger RC, Shankar A, Gupte N, Mave V. Mobile Health and Behavioral PMTCT Intervention among Community Health Workers Improves Exclusive Breastfeeding and Early Infant Diagnosis in India: A Cluster...

Inflammation in HIV-Infected Pregnant Women is Associated with Pre-term Birth

Post Date: 
2018-03-07
   |   
Countries: 
   |   
Clinical Sites: 
Shivakoti R , Gupte N, Kumar NP, Kulkarni V, Balasubramanian U, Bhosale R, Sambarey P, Kinikar A, Bharadwaj R, Patil S, Inamdar S, Suryavanshi N, Babu S, Bollinger R, Gupta A. Inflammation in HIV-Infected Pregnant Women is Associated with Pre-term Birth. CROI 2018. Boston, MA. 2018

Delays and Barriers to Early Treatment Initiation for Childhood Tuberculosis in India

Post Date: 
2017-10-13
   |   
Clinical Sites: 
Valvi C , Chandanwale A, Khadse A, Kulkarni R, Kadam D, Dhumal G, Bollinger RC, Deluca A. Delays and Barriers to Early Treatment Initiation for Childhood Tuberculosis in India. 48th Annual Union World Conference of Lung Health. Guadalajara, Mexico. October 13, 2017.

High Burden of Genital TB Among Women with Infertility in India - Need for an Intensified Approach

Post Date: 
2017-10-13
   |   
Clinical Sites: 
Naik SN , Chandanwale A, Joshi S, Mave V, Dhumal G, DeLuca A, Gupta A, Bollinger R. High Burden of Genital TB Among Women with Infertility in India - Need for an Intensified Approach. 48th Annual Union World Conference of Lung Health. Guadalajara, Mexico. October 13, 2017.

A Study to Compare Efficacy of Oral High Dose Rifampicin with Standard Dose Rifampicin in Tuberculous Meningitis

Post Date: 
2017-10-13
   |   
Clinical Sites: 
Basavaraj A , Avhad A, Kadam D. A Study to Compare Efficacy of Oral High Dose Rifampicin with Standard Dose Rifampicin in Tuberculous Meningitis. 48th Annual Union World Conference of Lung Health. Guadalajara, Mexico. October 13, 2017.

Prevalence of Vitamin D Deficiency among Indian Children with Tuberculosis and Age- and Sex-matched Controls

Post Date: 
2017-10-13
   |   
Clinical Sites: 
Kinikar A , Chandanwale A, Dixit S, Jubilus J, Jain S, Bharadwaj R, Mave V, Gupte N, DeLuca A, Gupta A, Bollinger RC. Prevalence of Vitamin D Deficiency among Indian Children with Tuberculosis and Age- and Sex-matched Controls. 48th Annual Union World Conference of Lung Health. Guadalajara, Mexico...

Barriers to Contact Screening and Isoniazid Preventive Therapy among Pediatric Contacts of Adults with Smear-positive Tuberculosis

Post Date: 
2017-10-12
   |   
Clinical Sites: 
Belgaumkar V , Chandanwale A, Valvi C, Khadse S, Jain D, Dhumal G, Bollinger RC, Deluca A. Barriers to Contact Screening and Isoniazid Preventive Therapy among Pediatric Contacts of Adults with Smear-positive Tuberculosis. 48th Annual Union World Conference of Lung Health. Guadalajara, Mexico.

Delays and Barriers to Early Treatment Initiation in Childhood Tuberculosis in India

Post Date: 
2017-10-11
   |   
Countries: 
Valvi C, Chandanwale A, Khadse S, Kulkarni R, Kadam D, Dhumal G , Deluca A, Bollinger RC. Delays and Barriers to Early Treatment Initiation in Childhood Tuberculosis in India. The 48th Union World Conference on Lung Health. Guadalajara, Mexico.

Lack of TB Knowledge among TST positive Household Contacts of Pulmonary Cases: A Missed Opportunity

Post Date: 
2017-10-11
   |   
Countries: 
DeLuca, A., Dhumal, G., Paradkar, P., Suryavanshi, N., Mave, V., Kohli, K., Shivakumar, S., Gupta. A. Lack of TB Knowledge among TST positive Household Contacts of Pulmonary Cases: A Missed Opportunity. The 48th Union World Conference on Lung Health. Guadalajara, Mexico.

High Burden of Diabetes and Prediabetes among Adult Household Contacts of India

Post Date: 
2017-09-13
   |   
Countries: 
   |   
Clinical Sites: 
Shivakumar SVBY , Chandrasekaran P, Kumar AJMV, Paradkar M, Dhanasekaran K, Suryavanshi N, Thomas B, Kohli R, Thiruvengadam K, Kulkarni V, Hannah LE, Sivaramakrishnan GN, Pradhan N, Dolla C, Gupte A, Ramachandran G, DeLuca A, Meshram S, Bhardawaj R, Bollinger RC, Golub J, Selvaraj K, Gupte N,...

How Americans Benefit from Global Health Research

Post Date: 
2017-05-25
   |   
Countries: 
Bollinger, R. How Americans Benefit from Global Health Research. The Fogarty International Center: How Americans Benefit from Global Health Research Webinar, Research!America. Washington, DC.

Outreach Workers in the Prevention of Mother to Child Transmission of HIV (PMTCT) Programme in India: Challenges and Opportunities

Post Date: 
2016-07-21
   |   
Countries: 
   |   
Clinical Sites: 
Suryavanshi N , Mave V, Kadam A, Kanade S, Sivalenka S, Sampath K, Harve P, Gupta RS, Hegde A, McKenzie-White J, Gupte N, Gupta A, Bollinger RC, Shankar AV. Outreach Workers in the Prevention of Mother to Child Transmission of HIV (PMTCT) Programme in India: Challenges and Opportunities. 21st...

Pages

Amit Kale, MS: Orthopedics

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
I am working as associate professor in orthopedics. Currently, I am conducting various drug trials for rheumatoid arthritis.

Anita Basavaraj, MD: Gastroenterology

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Dr Anita Basavaraj has done her MBBS from Nagpur University with Honors in Surgery (1987). Thereafter she did her MD in Medicine (1990) and her Diplomat of National Board (D.N.B.) in 1992.She has done her post graduate Diploma in geriatric Medicine (P.G.D.G.M.) winning the university Gold Medal by virtue of standing first in the country (2012), which is a distant education venture run by Indira Gandhi National Open University (IGNOU).

Geeta Shrikar Pardeshi, MD: Preventive and Social Medicine

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
I have led research projects related to Reproductive and Child Health, Sanitation and Infectious diseases. As part of the BJGMC JHU Fogarty training program in HIV-TB, I have research interest in TB epidemiology. I am interested in studying the association of co-morbidities with clinical presentation and treatment outcomes in tuberculosis.

Sunita Girish, PhD: Medical Biochemistry

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Education : Ph.D, Pune University, 2005 (Medical Biochemistry) title “Antioxidant Status in Leprosy.” Overview : How to improve health systems to combat various infectious diseases like Leprosy, Tuberculosis and HIV in developing countries, is a research and policy issue that affects many aspects of public health. My research interests include further to understand molecular level changes in cystic fibrosis which is under diagnosed .My interests also involve innovations in molecular techniques dealing with infectious diseases, help governments in developing countries to improve and modify...

Sangita Shelke, MD: Preventive and Social Medicine; Diplomas in Nutrition, Hospital Administration, Psychological counseling

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Indeed TB is a social disease with so many social problems especially the women suffering from TB/HIV undergoes a pathetic life situation. Women are silent suffers, of both HIV and TB in male dominated society of India. My ultimate desire is if I can make a difference in the lives of these silent suffers.

Dr. Smita Deshpande: Microbiology

BJGMC-JHU Fogarty HIV-TB Program Trainee
My research interests have been: Rapid diagnostic methods for Acute pyogenic meningitis, Diagnosis of enteric fever , Role of Methicillin resistance Staph aureus in infections, Molecular diagnosis of Leptospirosis, Rapid diagnosis of MDR-TB by REMA ( Resasurine Micro titre Plate Assay)and by Line Probe Assay.

Dr. Chhaya Valvi: Pediatrics

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Dr. Chhaya Valvi has completed her undergraduate and postgraduate medical education from the premier institute of Seth G.S. Medical College, Mumbai, India. She was awarded the prestigious Dr. Palekar prize as she ranked first among the candidates for M.D. exam.

Dr. Vasudha Belgaumkar: Dermatology

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Dr.Vasudha has completed her undergraduate medical education from S.B.H. Government Medical College, Dhule,Maharashtra .A meritorious student throughout, she topped her first and final year University examinations. She is presently working as Associate Professor of Dermatology at B.J. Government Medical College, Pune. Having completed her post-graduation in Dermatology, Venereology (including HIV) and Leprology from this premier institute, she has acquired clinical skills as well as an affinity for research.

Rahul Lokhande, MD: Pulmonary Medicine

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
He is Unit In charge at B J Government Medical college and Sassoon Hospital Pune . He has special Interest in Bronchoscopy and Respiratory Intensive Care Unit of Sassoon Hospital.

Dr. Shilpa Naik: Obstetrics and Gynecology

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
I am working as an Associate Professor & Unit Incharge since 2009 in the Department of Obstetrics & Gynecology at B.J.Govt Medical College & Sassoon General Hospitals Pune. I have been managing High Risk Obstetrics and has keen interest in Critical Care Obstetrics.

Akshay Gupte, PhD, MBBS, MSPH

Junior Investigator
Akshay Gupte
Akshay Gupte is a junior investigator trained in medicine, clinical research, and global health. His research interests include exploring approaches to host directed adjuvant therapies in tuberculosis (TB) and studying the impact of TB and HIV on lung health of populations. Dr. Gupte leads an Indo-US collaborative study exploring the impact of TB disease; alone and in combination with smoking, air pollution, HIV and diabetes mellitus; on respiratory impairment and risk of chronic obstructive pulmonary disease in India. He is also a co-investigator on the CTRIUMPH study—a multi-center cohort...

Akshay Gupte, PhD, MBBS, MSPH, PhD

Instructor of Medicine
Akshay Gupte
Dr. Gupte is Instructor of Medicine at CCGHE. His research focuses on the intersection of infectious and chronic lung diseases in low- and middle-income countries. Dr. Gupte leads several Indo-US collaborative studies to describe the epidemiology and pathogenesis of lung impairment in TB/HIV/diabetes, measure its impact on poor clinical outcomes, and identify therapeutic and programmatic interventions to improve post-TB lung health and longevity. He is an active member of several multi-national TB/HIV research consortia such as the TB Transformative Science Working Group of the ACTG, the TB...

Jeff Tornheim, MD, MPH

Infectious Disease Fellow
Baltimore, Maryland
Jeff Tornheim, MD, MPH, is a clinical fellow in the Division of Infectious Disease here at Johns Hopkins University School of Medicine. After completing undergraduate studies in International Development and Economics at Brandeis University he moved to East Africa where he engaged in health system strengthening for returning refugees to South Sudan and worked with the Centers for Disease Control and Prevention (CDC) on the epidemiology of pneumonia and diarrhea in Western Kenya. He completed a joint MD/MPH at Mount Sinai School of Medicine, with his thesis evaluating the impact of water...

Aarti Avinash Kinikar, MD: Pediatrics

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Education : MBBS (1984); DCH (1988); MD-Paediatrics (1988), DNB-Paediatrics (2003); MRCP-UK (1995). Medical Education- Grant Medical College – Mumbai University, India.

Experts say COVID-19 mutations are normal

Post Date: 
2021-01-15
Dr. Robert Bollinger: “... As with any virus, changes are something to be watched, to ensure that testing and vaccines are still effective.

Indonesia: Raging pandemic offers fertile ground for new variants

Post Date: 
2021-07-23
Source: 
Al Jazeera
Dr. Robert Bollinger
Al Jazeera: Dr. Robert Bollinger weighs in on the potential for new COVID-19 variants, particularly in areas where case numbers are high.

How we solved COVID

Post Date: 
2021-07-13
Source: 
Readers digest
Dr. Robert Bollinger
Dr. Robert Bollinger: "Such fast development of tests and vaccines are a clear example of the collaboration between scientists and the importance of public investment."

Are COVID-19 symptoms different if I’m infected with the Delta variant?

Post Date: 
2021-07-13
Source: 
Los Angeles Times
Dr. Robert Bollinger
Dr. Bollinger: "People getting infected now are a lot younger than they were with the earlier variants, because the older people are vaccinated at a much higher rate."

CURE ID Moves to Automated Data Collection in Light of COVID Pandemic

Post Date: 
2021-07-13
Dr. Matt Robinson
Drs. Matt Robinson is leading JHU efforts in this FDA program, and Robert Bollinger and Jane McKenzie-White helped launch it before COVID.

A vaccinated person's guide to the most concerning COVID-19 strains

Post Date: 
2021-06-22
Source: 
Salon
Dr. Robert Bollinger
Dr. Robert Bollinger. "Flu viruses are particularly prone to mutation, which is why new strains circulate every year."

Do Vaccine Incentives Work? Krispy Kreme Says The Freebies Helped

Post Date: 
2021-06-22
Source: 
Eminetra
Dr. Robert Bollinger
Dr. Bollinger: “It depends on what barriers people have when they get vaccinated. The higher those barriers, the harder it is to overcome."

Videos claiming vaccination efforts are causing new COVID-19 variants are fake

Post Date: 
2021-06-22
Source: 
Dunya News
Dr. Robert Bollinger
Dr. Bollinger: "Compared to unvaccinated people, vaccinated people are less likely to get infected by all of the strains, including the variants."

Can the U.S. Meet President Biden's Latest Vaccination Goal?

Post Date: 
2021-05-13
Source: 
Leslie Marshall Show
Dr. Robert Bollinger
Leslie and Dr. Bollinger discuss President Biden's new goal of having 70% of American adults receive at least their first COVID-19 vaccine dose by July 4th.

Will your child’s school mandate Covid vaccinations?

Post Date: 
2021-05-12
Source: 
CNBC
Dr. Robert Bollinger
Dr. Robert Bollinger: "It's always better to reinforce positive behavior rather than mandate, but we have a precedent of requiring vaccinations to go to school."

Fact Check-Vaccinated people are not ‘biological time bombs’ carrying coronavirus ‘super strains’

Post Date: 
2021-04-27
Source: 
Reuters
Dr. Robert Bollinger
Reuters: Dr. Bob Bollinger weighs in about misinformation spread in a COVID-19 conspiracy blog.

Dr. Bollinger: We’re in a better place with Covid, but we’re not out of the woods yet

Post Date: 
2021-03-15
Source: 
CNBC: The News with Shepard Smith
Dr. Robert Bollinger
CNBC: Dr. Bolllinger discusses COVID-19 variants and what's known about the AstraZeneca vaccine

World Renowned Infectious Disease Expert on CDC's New School Guidelines.

Post Date: 
2021-02-15
Source: 
Leslie Marshall Show
Dr. Robert Bollinger
Leslie Marshall interviews Dr. Robert Bollinger on CDC's New School Guidelines.

Will the New COVID-19 Variants Increase Reinfection Rates?

Post Date: 
2021-02-15
Source: 
VeryWellHealth
Dr. Robert Bollinger
"While the mutations don’t mean much in terms of how the virus functions, if the mutations lead to a change in how the virus works, then we pay more attention to it."

Should You Double Mask in the Workplace?

Post Date: 
2021-02-14
Source: 
Inc.
Dr. Robert Bollinger
You don't want the mask to be uncomfortable. "The most important mask is the one you're going to wear all the time when you're in high-risk situations," says Dr. Bob Bollinger.

What do teachers mean when they say they don't have 'adequate' PPE?

Post Date: 
2021-02-03
Source: 
Independent Tribune
Dr. Robert Bollinger
Dr. Bollinger: “There are 17 genetic changes in the B.1.1.7 variant from England. There’s some preliminary evidence that it’s more contagious."

Des Moines County supervisors hone their budget chops

Post Date: 
2021-02-02
Source: 
The Hawk Eye
Dr. Robert Bollinger
“All RNA viruses mutate over time, some more than others. For example, flu viruses change often, which is why doctors recommend that you get a new flu vaccine every year."

Experts Explain How To Effectively Wear Two Face Masks

Post Date: 
2021-02-01
Source: 
Bustle
Dr. Robert Bollinger
"Some of the new SARS-CoV2 variants appear to be more infectious and easier to transmit, so although we don’t have clear data yet, it makes sense that more effective masking might help."

When will it end?

Post Date: 
2021-02-01
Source: 
TheStar
Dr. Robert Bollinger
Dr. Bollinger: “We are not seeing any indication that the new strain is more virulent or dangerous in terms of causing more severe Covid-19 diseases.”

How Dangerous Are the New COVID-19 Variants?

Post Date: 
2021-01-29
Source: 
Global Citizen
Dr. Robert Bollinger
Dr. Robert Bollinger: “[RNA] viruses are notorious for having variants because every time they copy themselves inside a new infected person, they're sloppy."

The New Strain of COVID-19: How Much More Dangerous Is It?

Post Date: 
2021-01-27
Source: 
Radio Health Journal
Dr. Robert Bollinger
Dr. Bob Bollinger was interviewed about the new strain of COVID-19 for this live radio broadcast.

Pages